A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

December 31, 2003

Conditions
Malaria
Interventions
DRUG

Sulfadoxine/pyrimethamine and artesunate

Trial Locations (1)

BP 1386

Institut de recherche pour le developpement, Dakar

All Listed Sponsors
collaborator

Institut de Recherche pour le Developpement, Senegal

OTHER

collaborator

Institut de Recherche pour le Developpement

OTHER_GOV

collaborator

Cheikh Anta Diop University, Senegal

OTHER

collaborator

Ministry of Health, Senegal

OTHER_GOV

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00132561 - A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children | Biotech Hunter | Biotech Hunter